111 related articles for article (PubMed ID: 18498074)
21. Vascular endothelial growth factor, c-erbB-2 and c-erbB-3 expression in colorectal adenoma and adenocarcinoma.
Uner A; Ebinc FA; Akyurek N; Unsal D; Mentes BB; Dursun A
Exp Oncol; 2005 Sep; 27(3):225-8. PubMed ID: 16244586
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of c-erbB-2 and loss of p16 have molecular diagnostic relevance but no prognostic value in lung cancer.
Feng XL; Li L; Gao YN; Zhang JJ; Xiao T; Ying JM; Gao JD; Sun YT; Cheng SJ
Med Oncol; 2011 Mar; 28(1):336-41. PubMed ID: 20237870
[TBL] [Abstract][Full Text] [Related]
23. β-arrestin1 over-expression is associated with an unfavorable prognosis in lung adenocarcinomas and correlated with vascular endothelial growth factor.
Qiu C; Zheng C; Zhu L; Qu X; Shen H; Du J
Int J Clin Exp Pathol; 2015; 8(4):3785-93. PubMed ID: 26097560
[TBL] [Abstract][Full Text] [Related]
24. Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival.
Aaltomaa S; Lipponen P; Ala-Opas M; Eskelinen M; Syrjänen K; Kosma VM
Br J Cancer; 1999 Aug; 80(12):2001-7. PubMed ID: 10471053
[TBL] [Abstract][Full Text] [Related]
25. [Expressions of human epidermal growth factor receptor 2 and vascular endothelial growth factor in primary or recurrent metastatic breast cancers].
Wang ZK; Meng HY; Han C; Yang JL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Aug; 32(4):403-6. PubMed ID: 20868598
[TBL] [Abstract][Full Text] [Related]
26. Vascular endothelial growth factor-C and its receptor VEGFR-3 in non-small-cell lung cancer: concurrent expression in cancer cells from primary tumour and metastatic lymph node.
Saintigny P; Kambouchner M; Ly M; Gomes N; Sainte-Catherine O; Vassy R; Czernichow S; Letoumelin P; Breau JL; Bernaudin JF; Kraemer M
Lung Cancer; 2007 Nov; 58(2):205-13. PubMed ID: 17686546
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of P-glycoprotein, HER-2/ErbB-2, p53, and Bcl-2 in primary tumor and metachronous lung metastases in patients with high-grade osteosarcoma.
Ferrari S; Bertoni F; Zanella L; Setola E; Bacchini P; Alberghini M; Versari M; Bacci G
Cancer; 2004 May; 100(9):1936-42. PubMed ID: 15112275
[TBL] [Abstract][Full Text] [Related]
28. Role of COX-2, VEGF and cyclin D1 in mammary infiltrating duct carcinoma.
Lim SC
Oncol Rep; 2003; 10(5):1241-9. PubMed ID: 12883688
[TBL] [Abstract][Full Text] [Related]
29. A risk-stratification model of non-small cell lung cancers using cyclin E, Ki-67, and ras p21: different roles of G1 cyclins in cell proliferation and prognosis.
Dosaka-Akita H; Hommura F; Mishina T; Ogura S; Shimizu M; Katoh H; Kawakami Y
Cancer Res; 2001 Mar; 61(6):2500-4. PubMed ID: 11289121
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma.
Arinaga M; Noguchi T; Takeno S; Chujo M; Miura T; Uchida Y
Cancer; 2003 Jan; 97(2):457-64. PubMed ID: 12518370
[TBL] [Abstract][Full Text] [Related]
31. CyclinD1, p53, E-cadherin, and VEGF discordant expression in paired regional metastatic lymph nodes of esophageal squamous cell carcinoma: a tissue array analysis.
Luo KJ; Hu Y; Wen J; Fu JH
J Surg Oncol; 2011 Sep; 104(3):236-43. PubMed ID: 21480261
[TBL] [Abstract][Full Text] [Related]
32. Expressions of ER, PR, HER-2, COX-2, and VEGF in primary and relapsed/metastatic breast cancers.
Sun L; Yu DH; Sun SY; Zhuo SC; Cao SS; Wei L
Cell Biochem Biophys; 2014 Apr; 68(3):511-6. PubMed ID: 23955549
[TBL] [Abstract][Full Text] [Related]
33. Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.
Giatromanolaki A; Koukourakis MI; Kakolyris S; Turley H; O'Byrne K; Scott PA; Pezzella F; Georgoulias V; Harris AL; Gatter KC
Clin Cancer Res; 1998 Dec; 4(12):3017-24. PubMed ID: 9865915
[TBL] [Abstract][Full Text] [Related]
34. Differential expression of biomarkers in primary non-small cell lung cancer and metastatic sites.
Gomez-Roca C; Raynaud CM; Penault-Llorca F; Mercier O; Commo F; Morat L; Sabatier L; Dartevelle P; Taranchon E; Besse B; Validire P; Italiano A; Soria JC
J Thorac Oncol; 2009 Oct; 4(10):1212-20. PubMed ID: 19687761
[TBL] [Abstract][Full Text] [Related]
35. Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) levels, as prognostic indicators in NSCLC.
Iwasaki A; Kuwahara M; Yoshinaga Y; Shirakusa T
Eur J Cardiothorac Surg; 2004 Mar; 25(3):443-8. PubMed ID: 15019676
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer.
Carrillo de Santa Pau E; Arias FC; Caso Peláez E; Muñoz Molina GM; Sánchez Hernández I; Muguruza Trueba I; Moreno Balsalobre R; Sacristán López S; Gómez Pinillos A; del Val Toledo Lobo M
Cancer; 2009 Apr; 115(8):1701-12. PubMed ID: 19197998
[TBL] [Abstract][Full Text] [Related]
37. Cyclin D1 overexpression is an indicator of poor prognosis in resectable non-small cell lung cancer.
Keum JS; Kong G; Yang SC; Shin DH; Park SS; Lee JH; Lee JD
Br J Cancer; 1999 Sep; 81(1):127-32. PubMed ID: 10487623
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors in stage T1 grade 3 bladder cancer survival: the role of G1-S modulators (p53, p21Waf1, p27kip1, Cyclin D1, and Cyclin D3) and proliferation index (ki67-MIB1).
Lopez-Beltran A; Luque RJ; Alvarez-Kindelan J; Quintero A; Merlo F; Carrasco JC; Requena MJ; Montironi R
Eur Urol; 2004 May; 45(5):606-12. PubMed ID: 15082203
[TBL] [Abstract][Full Text] [Related]
39. [Interleukin 7 and its receptor promote cell proliferation and induce lymphangiogenesis in non-small cell lung cancer].
Ming J; Zhang QF; Jiang YD; Jiang GC; Qiu XS
Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):511-8. PubMed ID: 23157741
[TBL] [Abstract][Full Text] [Related]
40. Expression of cell cycle control proteins in primary colorectal tumors does not always predict expression in lymph node metastases.
McKay JA; Douglas JJ; Ross VG; Curran S; Ahmed FY; Loane JF; Murray GI; McLeod HL
Clin Cancer Res; 2000 Mar; 6(3):1113-8. PubMed ID: 10741741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]